News
White House Unveils Sweeping AI Action Plan to Boost Development
The Trump administration called for boosting artificial intelligence development in the US by loosening regulations and expanding energy supply for data centers under new guidelines that also urged the federal government to withhold funding from states determined to have burdensome regulations on the emerging technology.
Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...
Key Points Traditional companies in banking, agriculture, and materials are quietly deploying artificial intelligence (AI) to transform operations and create competitive advantages that investors are ...
The artificial intelligence moment is upon humanity. Unfortunately, there is no going back except the mind-boggling ...
AI is dumbing us down. But paradoxically, when used judiciously in combination with human thought, the very same tool could ...
The artificial intelligence (AI) market expanded rapidly in recent years as new generative AI platforms like OpenAI's ChatGPT ...
OpenAI convinced a federal judge in California on Monday that a Silicon Valley tech entrepreneur violated its trademark rights by using the name "Open AI" in commerce.
As artificial intelligence transforms how we order food and how restaurants connect with customers, let's take a look at a ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
America Uncovered on MSN1d
How Artificial Intelligence Is Transforming Our CareersArtificial Intelligence is reshaping the job market faster than ever. This video explores how AI will impact careers and what ...
Subtle asymmetries in a horse's movement can be easy to miss, especially under time pressure or with unfamiliar horses; an ...
3hon MSN
Nvidia's GPUs are powering the AI arms race. Nvidia is poised for massive upside if the projection proves to be true. Nvidia (NASDAQ: NVDA) has is now the world's largest company, creating a sizable ...
Clinical trials remain the cornerstone of evidence-based medicine, yet they are frequently protracted and costly. More often than commonly thought, clinical trials are also uninformative.1 Artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback